BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11504103)

  • 1. Early proactive management of vestibular schwannomas in neurofibromatosis type 2.
    Brackmann DE; Fayad JN; Slattery WH; Friedman RA; Day JD; Hitselberger WE; Owens RM
    Neurosurgery; 2001 Aug; 49(2):274-80; discussion 280-3. PubMed ID: 11504103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
    Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
    J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
    Samii M; Matthies C; Tatagiba M
    Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing preservation in neurofibromatosis type 2.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
    Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.
    Slattery WH; Fisher LM; Hitselberger W; Friedman RA; Brackmann DE
    J Neurosurg; 2007 Apr; 106(4 Suppl):255-60. PubMed ID: 17465357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
    Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
    Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
    Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
    Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.
    Chen LH; Zhang HT; Xu RX; Zhang L; Li WD; Sun K
    Medicine (Baltimore); 2018 Apr; 97(17):e0270. PubMed ID: 29702972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle fossa approach for hearing preservation with acoustic neuromas.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1997 Sep; 18(5):596-601. PubMed ID: 9303156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscope-assisted middle fossa craniotomy for resection of inferior vestibular nerve schwannoma extending lateral to transverse crest.
    Master AN; Roberts DS; Wilkinson EP; Slattery WH; Lekovic GP
    Neurosurg Focus; 2018 Mar; 44(3):E7. PubMed ID: 29490550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
    Arts HA; Telian SA; El-Kashlan H; Thompson BG
    Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Facial nerve function and hearing preservation experience in middle fossa approach removal of small acoustic tumor surgery].
    Yu JB; Wu H; Huang Q; Yang J; Wang ZY; Lü JR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Oct; 48(10):793-7. PubMed ID: 24406173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Preservation After Planned Partial Resection Followed by Gamma Knife Radiosurgery for Large Vestibular Schwannomas.
    Iwai Y; Ishibashi K; Watanabe Y; Uemura G; Yamanaka K
    World Neurosurg; 2015 Aug; 84(2):292-300. PubMed ID: 25790872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing preservation using the middle fossa approach for the treatment of vestibular schwannoma.
    Kutz JW; Scoresby T; Isaacson B; Mickey BE; Madden CJ; Barnett SL; Coimbra C; Hynan LS; Roland PS
    Neurosurgery; 2012 Feb; 70(2):334-40; discussion 340-1. PubMed ID: 21826031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.